• 대한족부족관절학회지
• /
• 제16권1호
• /
• pp.47-52
• /
• 2012

Purpose: The purpose of this study is to evaluate the effect of axial shortening metatarsal osteotomy on the treatment of advanced rheumatoid arthritis patients with severe hallux valgus and claw toe deformity of lesser toes which is used for preserving the metatarsophalangeal joint. Materials and Methods: From January 2005 to June 2009, 18 cases of axial shortening metatarsal osteotomy in advanced rheumatoid arthritis were reviewed ; all of them followed up for more than 2 years after surgical procedures and the mean follow up period was 3.4 years. We performed axial shortening Scarf osteotomy and Akin osteotomy for hallux valgus and Weil osteotomy with soft tissue release for claw toe of lesser toes, respectively. We measured preoperative and postoperative hallux valgus angle, each metatarsal shortening length and the range of motion of the metatarsophalangeal joints through radiographic and clinical examination and compared them each other. Clinical results were evaluated by American Orthopedic Foot and Ankle Society (AOFAS) score and subjective satisfaction of the patients. Results: The hallux valgus angle was reduced from the preoperative mean value of 44.8 degree to 9.0 degree postoperatively and the range of motion of the metatarsophalangeal joint of great toe and lesser toes was increased from the mean of 21.7 degree and 11.0 degree preoperatively to 38.0 degree and 32.5 degree, respectively at postoperation. Also, the mean AOFAS score was improved from 26.5 points to 67.4 points. Conclusion: Axial shortening osteotomy is a useful method to correct the deformity and preserve the metatarsophalangeal joint for severe hallux valgus and claw toe deformity in advanced rheumatoid arthritis.

• 한국식품영양과학회지
• /
• 제38권4호
• /
• pp.442-450
• /
• 2009

후추의 주요 성분인 piperine은 다양한 생리활성을 나타내고 있으며, 특히 암예방 효과가 있는 것으로 생각되고 있다. 본 연구에서는 piperine의 항암 효과를 밝히기 위해 piperine이 인간의 대장에서 유래한 암세포인 HT-29 세포의 증식에 미치는 영향과 작용 기전을 연구하였다. Piperine을 HT-29 세포 배양액에 여러 농도($0{\sim}40{\mu}M$)로 첨가하여 세포를 배양한 경우 piperine 처리 농도가 증가할수록 세포의 증식이 감소하였고, 세포사멸이 증가하였다. 이는 piperine이 HT-29 세포의 세포사멸을 유도하여 세포 증식을 억제함을 제시한다. Piperine의 세포사멸 기전을 조사하기 위해 세포사멸 조절인자의 변화를 조사하였다. Piperine에 의해 anti-apoptotic Bcl-2 family 단백질인 Bcl-2와 Mcl-1 단백질 수준은 감소하였고, BH3-only 단백질인 Bid 단백질 수준은 감소하였으나, Bik 단백질 수준은 증가하였다. 또한 piperine에 의해 미토콘드리아 막의 투과성이 증가하였고, cytochrome c의 세포질로의 방출이 증가하였다. 또한 piperine 처리에 의해 caspase의 활성형인 cleaved caspase-8, -9, -7, -3 단백질 수준이 증가하였고, PARP의 불활성형인 cleaved PARP 수준이 증가하였다. Caspase의 활성을 저해하는 세포사멸억제단백질 중의 하나인 survivin 단백질 발현이 piperine에 의해 감소하였다. 이 결과로부터 대장암세포인 HT-29 세포에서 piperine이 Bcl-2 family 단백질 발현 변화를 초래하여 미토콘드리아 막 투과성 증가시키고 cytochrome c 방출을 증가시키고, caspase 활성을 증가시키고 survivin 단백질 발현을 억제하여 세포사멸을 유도하여 항암 효과를 나타냄을 알 수 있다. 본 연구는 piperine이 대장암에 강한 항암 효과가 있음을 밝혔으나 향후 암예방 및 암치료제로서 piperine을 활용하기 위해서는 동물실험 및 임상실험 등 다양한 추가 실험이 필요할 것으로 보인다.

• 한국식품과학회지
• /
• 제46권4호
• /
• pp.483-488
• /
• 2014

브로콜리(Brassica oleracea var. italica) 잎의 n-hexane, chloroform, ethyl acetate, butanol 및 distilled water 분획물의 total phenolic 화합물 함량은 chloroform 분획물이 206.8 mg GAE/g으로 가장 높게 나타났으며, ABTS radical 소거활성 및 지질 과산화(MDA) 생성 억제효과 실험 결과에서 chloroform 분획물에서 가장 높은 활성을 나타내었다. in vitro 항산화 실험들에서 우수한 효과를 보인 chloroform 분획물을 이용하여 $H_2O_2$으로 유도한 산화적 스트레스에 대한 신경세포(PC12 cell)에서의 산화적 스트레스 생성 억제효과, 세포 생존율 그리고 세포막 손상 억제효과 역시 농도 의존적 경향을 나타내며 positive control 로 사용된 Vit.C와 유의적인 결과를 나타냈다. 마지막으로, HPLC 분석 결과 브로콜리 잎 chloroform 분획물에 존재하는 주요 phenolic 화합물은 feulic acid인 것으로 확인되었다. 본 연구 결과를 종합해볼 때, 생리활성 물질로서의 ferulic acid 등을 함유한 브로콜리 잎 chloroform 분획물은 in vitro 항산화 활성과 함께 신경세포 보호효과를 나타내는 고부가가치 기능성 소재로의 활용이 기대된다.

• Journal of Dental Anesthesia and Pain Medicine
• /
• 제20권3호
• /
• pp.129-135
• /
• 2020

Background: Postoperative fluid retention is a factor that causes delay in recovery and unexpected adverse events. It is important to prevent intraoperative fluid retention, which is putatively caused by intraoperative release of stress hormones, such as ADH (anti-diuretic hormone) or others. We hypothesized that intraoperative analgesia may prevent pathological fluid retention. We retrospectively explored the relationship between analgesics and in-out balance in surgical patients from anesthesia records. Methods: Anesthetic records of 80 patients who had undergone orthognathic surgery were checked in this study. Patients were anesthetized with either TIVA (propofol and remifentanil) or inhalational anesthesia (sevoflurane and remifentanil). During surgery, acetated Ringer's solution was infused for maintenance at a rate of 3-5 ml/kg/h at the discretion of the anesthetist. The perioperative parameters, including the amount of crystalloid and colloid infused, and the amount of urine and bleeding were checked. Furthermore, we checked the amount and administration rate of remifentanil during the surgical procedure. The correlation coefficient between the remifentanil dose and the in-out balance or the urinary output was analyzed using the Pearson correlation coefficient. The contributing factor to fluid retention, including urinary output, was statistically examined by means of multivariate logistic regression analysis. Results: A significant positive correlation was found between remifentanil dose and urinary output. Urinary output less than 0.04 ml/kg/min was suggested to cause positive fluid balance. Although in-out balance approaches zero balance with increase in remifentanil administration rate, no contributing factor for near-zero fluid balance was statistically picked up. The remifentanil administration rate was statistically picked up as the significant factor for higher urinary output (> 0.04 ml/kg/min) (OR, 2,644; 95% CI, 3.2-2.2 × 10⁶) among perioperative parameters. Conclusions: In conclusion, remifentanil contributes in maintaining the urinary output during general anesthesia. Although further prospective study is needed to confirm this hypothesis, it was suggested that fluid retention could be avoided through suppressing intraoperative stress response by means of appropriate maintenance of remifentanil infusion rate.

• Restorative Dentistry and Endodontics
• /
• 제32권3호
• /
• pp.191-197
• /
• 2007

이 연구의 목적은 치주인대 섬유아세포에 MTA를 접촉시킨 뒤 성장인자 transforming growth factor-beta1 $(TGF-\beta1)$, fibroblast growth factor-2 (FGF-2) 및 cytokine interleukin-6 (IL-6)의 발현량 변화를 측정하는 것이다. MTA군에서는 100 mg씩의 ProRoot MTA와 증류수를 혼합하고, IRM군은 동량의 IRM 분말을 용액에 혼합하여 이 시료들을 경화반응이 진행되도록 7일간 놓아두었다. 사람의 치주인대 섬유아세포를 배양하여 MTA와 IRM시료 상에 well당 $1\times10^5$개 수준으로 도포한뒤 6, 12, 24, 48시간 동안 배양하였다 (n = 5). 대조군으로는 재료의 접촉 없이 배양한 세포를 사용하였다. 시료에서 상층액을 분리하여 $TGF-\beta1$, FGF-2, IL-6의 발현량을 enzyme-linked immunosorbent assay (ELISA)법으로 측정하였다. MTA군에서, 성장인자인 $TGF-\beta1$과 FCF-2는 대조군에 비해 유의성 있게 발현이 억제되었으며 (p < 0.05), cytokine인 IL-6 발현량은 대조군과 유사한 수준으로 나타났다.

• Applied Microscopy
• /
• 제37권1호
• /
• pp.1-10
• /
• 2007

MCT 유발 간독성 흰쥐에 해독정기탕의 투여가 시간경과에 따른 간세포의 항산화효소 활성변화, 세포사멸 억제와 간의 조직병리학적 변화에 미치는 영향을 조사하였다. 대조군은 생리식염수를 투여하였으며, 실험군은 해독정기탕 0.9 mL을 6시간, 24시간 간격으로 경구투여 하였다. 간기능의 지표가 되는 GPT 효소 활성은 해독정기탕 투여한 6시간 군에서 대조군에 비해 감소하였다. 항산화 효소인 SOD, catalase 활성도의 변화에 있어서도 6시간 실험군에서 변화를 보여주었고 24시간 경과 후에는 대조군과 실험군의 통계적인 유의성은 없었다. 간의 조직병리학적 관찰 결과 대조군은 심한 출혈, 간세포의 팽창과 중심정맥 내피세포의 파괴 현상이 뚜렷이 나타났으며, 24시간 경과 후에는 핵질의 응축과 사립체의 팽대현상이 현저하였다. 반면 해독정기탕 투여후 6시간 실험군은 일부 세포괴사와 세포사멸 보호 및 회복효과를 관찰하였다. 이상의 연구 결과로 보아 해독정기탕은 투여시간에 따라 간 기능회복 및 해독, 간세포의 항산화 활성변화, 세포사멸의 보호효과 약물로서 작용함이 사료된다.

• Journal of Pharmaceutical Investigation
• /
• 제32권1호
• /
• pp.47-54
• /
• 2002

Cimetropium bromide, a quaternary ammonium compound which is chemically related to scopolamine, exhibits its antispasmodic activity by competing with acetylcholine for the muscarinic receptors of the smooth muscle of gastrointestinal tract. The drug has been used for the treatment of various disorders involving spasms of the musculature of the gastrointestinal, biliary and genitourinary tracts. The purpose of the present study was to evaluate the bioequivalence of two cimetropium bromide tablets, $Algiron^{TM}$ (Boehringer Ingelheim Korea Ltd.) and $Alpit^{TM}$ (Hana Pharmaceutical Co., Ltd.), according to the prior and revised guidelines of Korea Food and Drug Administration (KFDA). The cimetropium bromide release from the two cimetropium bromide tablets in vitro was tested using KP VII Apparatus II method with various different kinds of dissolution media (pH 1.2, 4.0, 6.8 buffer solution and water). Twenty normal male volunteers, $25.25{\pm}2.10$ years in age and $65.76{\pm}6.39$ kg in body weight, were divided into two groups and a randomized $2{\times}2$ cross-over study was employed. After three tablets containing 50 mg of cimetropium bromide per tablet were orally administered, blood was taken at predetermined time intervals and the concentrations of cimetropium bromide in serum were determined using HPLC method with UV detector. The dissolution profiles of two cimetropium bromide tablets were very similar at all dissolution media. Besides, the pharmacokinetic parameters such as $AUC_t,\;C_{max}\;and\;T_{max}$ were calculated and ANOVA test was utilized for the statistical analysis of the parameters using non-transformed and logarithmically transformed $AUC_t\;and\;C_{max}$. The results showed that the differences in $AUC_t,\;C_{max}\;and\;T_{max}$ between two tablets based on the $Algiron^{TM}$ were 2.19%, -5.97% and 3.49%, respectively. Minimum detectable differences $({\Delta})\;at \;{\alpha}=0.05\;and\;1-{\beta}=0.8$ were less than 20% (e.g., 13.71 %, 19.05% and 15.11% for $AUC_t,\;C_{max}\;and\;T_{max}$, respectively). The powers $(1-{\beta})\;at\;{\alpha}=0.05,\;{\Delta}=0.2\;for\;AUC_t$, $C_{max}\;and\;T_{max}$ were 97.79%, 83.22% and 95.60%, respectively. The 90% confidence intervals were within ${\pm}20%$ (e.g., $-5.84{\sim}10.21,\;-17.11{\sim}5.18\;and\;-5.35{\sim}12.33\;for\;AUC_t,\;C_{max}\;and\;T_{max}$, respectively). There were no sequence effect between two tablets in logarithmically transformed $AUC_t\;and\;C_{max}$. The 90% confidence intervals using logarithmically transformed data were within the acceptance range of log(0.8) to log(1.25) (e.g., $0.94{\sim}1.10\;and\;0.85{\sim}1.05\;for\;AUC_t\;and\;C_{max}$, respectively). Two parameters met the criteria of prior and revised KFDA guideline for bioequivalence, indicating that $Alpit^{TM}$ tablet is bioequivalent to $Algiron^{TM}$ tablet.

• Journal of Microbiology and Biotechnology
• /
• 제22권12호
• /
• pp.1782-1789
• /
• 2012

We have developed a novel type of polymer nanogel loaded with anticancer drug based on bio-derived poly(${\gamma}$-glutamic acid) (${\gamma}$-PGA). ${\gamma}$-PGA is a highly anionic polymer that is synthesized naturally by microbial species, most prominently in various bacilli, and has been shown to have excellent biocompatibility. Thiolated ${\gamma}$-PGA was synthesized by covalent coupling between the carboxyl groups of ${\gamma}$-PGA and the primary amine group of cysteamine. Doxorubicin (Dox)-loaded ${\gamma}$-PGA nanogels were fabricated using the following steps: (1) an ionic nanocomplex was formed between thiolated ${\gamma}$-PGA as the negative charge component, and Dox as the positive charge component; (2) addition of poly(ethylene glycol) (PEG) induced hydrogen-bond interactions between thiol groups of thiolated ${\gamma}$-PGA and hydroxyl groups of PEG, resulting in the nanocomplex; and (3) disulfide crosslinked ${\gamma}$-PGA nanogels were fabricated by ultrasonication. The average size and surface charge of Dox-loaded disulfide cross-linked ${\gamma}$-PGA nanogels in aqueous solution were $136.3{\pm}37.6$ nm and $-32.5{\pm}5.3$ mV, respectively. The loading amount of Dox was approximately 38.7 ${\mu}g$ per mg of ${\gamma}$-PGA nanogel. The Dox-loaded disulfide cross-linked ${\gamma}$-PGA nanogels showed controlled drug release behavior in the presence of reducing agents, glutathione (GSH) (1-10 mM). Through fluorescence microscopy and FACS, the cellular uptake of ${\gamma}$-PGA nanogels into breast cancer cells (MCF-7) was analyzed. The cytotoxic effect was evaluated using the MTT assay and was determined to be dependent on both the concentration and treatment time of ${\gamma}$-PGA nanogels. The bio-derived ${\gamma}$-PGA nanogels are expected to be a well-designed delivery carrier for controlled drug delivery applications.

• 대한환경공학회지
• /
• 제22권1호
• /
• pp.83-89
• /
• 2000

벤토나이트는 매립지로부터 중금속이 유출되는 것을 저지시키기 위한 라이너 물질로 고려되고 있다. 본 연구에서는 국산 벤토나이트를 대상으로 구리 흡착실험을 수행하였으며, 평형관계식과 용액화학 및 반응온도가 구리흡착에 미치는 영향을 규명하였다. 구리의 흡착반응은 Freundlich 등온선을 비교적 잘 만족하였으며, 결정된 상수 $K_F=1.18$, n=1.65, 상관계수 $(r^2)=0.97$ 이었다. 구리이온의 분배계수는 주어진 초기용액의 농도범위에서 농도가 증가할수록 감소하였다. 구리이온의 분배계수는 pH가 증가할수록 증가하였으며, pH > 5.3 이상에서는 침전반응으로 인해 그 값이 급격하게 증가하였다. $Na^+$의 이온강도가 증가함에 따라 구리이온의 분배계수 값은 감소하였으며, 반면에 용액 중에 존재하는 $SO_4{^{2-}}$의 농도가 증가할 경우에는 그 값이 증가하였다. 그리고 온도가 증가함에 따라 구리이온의 분배계수는 서서히 감소하였다.

• The Korean Journal of Physiology and Pharmacology
• /
• 제4권1호
• /
• pp.47-54
• /
• 2000

Transition metal ions including $Se^{2+},\;Cd^{2+},\;Hg^{2+}\;or\;Mn^{2+}$ have been thought to disturb the bone metabolism directly. However, the mechanism for the bone lesion is unknown. In this study, we demonstrated that MC3T3E1 osteoblasts, exposed to various transition metal ions; selenium, cadmium, mercury or manganese, generated massive amounts of reactive oxygen species (ROS). The released ROS were completely quenched by free radical scavengers-N-acetyl cysteine (NAC), reduced glutathione (GSH), or superoxide dismutase (SOD). First, we have observed that selenium $(10\;{\mu}M),$ cadmium $(100\;{\mu}M),$ mercury $(100\;{\mu}M)$ or manganese (1 mM) treatment induced apoptotic phenomena like DNA fragmentation, chromatin condensation and caspase-3-like cysteine protease activation in MC3T3E1 osteoblasts. Concomitant treatment of antioxidant; N-acetyl-L-cysteine (NAC), reduced-form glutathione (GSH), or superoxide dismutase (SOD), prevented apoptosis induced by each of the transition metal ions. Catalase or dimethylsulfoxide (DMSO) has less potent inhibitory effect on the apoptosis, compared with NAC, GSH or SOD. In line with the results, nitroblue tetrazolium (NBT) stain shows that each of the transition metals is a potent source of free radicals in MC3T3E1 osteoblast. Our data show that oxidative damage is associated with the induction of apoptosis in MC3T3E1 osteoblasts following $Se^{2+},\;Cd^{2+},\;Hg^{2+}\;or\;Mn^{2+}$ treatment.